Good overview of MNO’s platform and capabilities:
https://www.railway-technology.com/contractors/training/corridor-ai
“5-year cyber security management deal with a major operator of franchised car dealerships”
Thoughts on who this client may be? The top 5 franchised dealers in UK are: Sytner, Lookers, Pendragon, Arnold Clark, Vertu
this was trading at over 3p less than a year ago, now there are real signs of growth.
IT spending in the private and public sector is only going up in these times, on cloud, networking, collaboration, security etc
Signs of a turnaround here, growing revenue and margins.
Some major client wins, with Boohoo and a major UK car franchise dealership (why didn’t they announce these contract wins to the market? it would have resulted in better support)
Asset value £5.7m v a current market cap of only £4m
Very similar, just a different variant of IFN.
Across the pond BetterLife are preparing to get their phase II started later this summer, in the meantime all eyes on are on SNG who are months ahead in clinical trials
We’re likely to hear an update on MNO’s rail contracts in the next couple of weeks now that we’re approaching the end of Q2. The contract with state owned Australian Rail Track Corporation (ARTC) is the one to watch as this should showcase the huge potential of the Corridor.ai product. Once this major client demonstrates the benefits and cost savings of the system, then other similar contract wins are sure fo follow, all on recurring revenue. The Americas region is high on the growth plans with appointment of Nicholas Wayne as Vice President Americas.
Also not forgetting the Nextcore product for drone based Lidar, where we can also see further contract wins.
BA’s furlough was due to end 30th June but as the resumption of flying has been impacted by UK quarantine they have told staff there is not enough work for them to return to yet and are extending the furlough to 31st July.
This may of course change if there is a quick u-turn on UK quarantine, but I think it will be relaxed gradually and not for all regions at once.
Not sure if posted earlier, more recent positive trial results showing Interferon works as a therapy for Covid.
This version of Interferon is slightly different to the type being trialed by SNG, but the Interferon family of drugs is increasingly being proven to be effective.
https://www.globenewswire.com/news-release/2020/06/19/2050659/0/en/BetterLife-Pharma-OTCQB-BETRF-Looks-to-Immune-Response-Drug-Interferon-a2b-as-Potential-Therapeutic-for-COVID-19.html
>>currently awaiting the construction authorization from MITECO, following a report from the Nuclear Safety Council (CSN), and the urban license from the Retortillo City Council<<
BKY needs both decisions to go their way to get a green light on the project.
Judging by the volume and price action, it’s quite possible that some info may have leaked about one of these decisions, but I would be surprised for both, as they are independent bodies.
Then again these decisions are made by involving a number of people and not so easy to keep confidential.